Mesoblast’s RYONCIL ® (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA approved mesenchymal ...

Mesoblast (MESO) announced that it has entered into the Medicaid National Drug Rebate Agreement, NDRA, with the U.S. Centers for Medicare & ...

Gladstone Capital's recent financial results showed stability, as the unchanged NII supports the ongoing dividend policy. See ...

Gene Zabezhinsky, an expert hedge fund manager, who previously was Portfolio Manager at Fiera Capital and Millennium Capital Partners, joined 4 Eyes Capital in December 2023 and manages the firm's ...

US Navy to christen future USNS Billy Frank Jr. in Alabama. Find the latest news from the maritime industry on the PortNews website.

Supporting the learning, teaching and research needs of the NTU community.